![Jim Kasinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jim Kasinger
General Counsel bei
CRISPR THERAPEUTICS AG
Vermögen: 5 Mio $ am 31.05.2026
Profil
James R.
Kasinger is currently Secretary & General Counsel at CRISPR Therapeutics AG since 2017.
Current memberships include the American Bar Association and the Boston Bar Association.
Former roles include Secretary & General Counsel at Moderna, Inc. from 2014 to 2017, General Counsel at PlumChoice, Inc. from 2011 to 2014, Partner at Goodwin Procter LLP from 2010 to 2011, Associate at Testa, Hurwitz & Thibeault LLP from 1997 to 2005, and General Counsel at ModernaTX, Inc. Education includes an undergraduate degree from Wheaton College (Illinois) in 1993 and a graduate degree from Boston College Law School in 1997.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.05.2026 | 94 308 ( 0,1 % ) | 5 Mio $ | 31.05.2026 |
Aktive Positionen von Jim Kasinger
| Unternehmen | Position | Beginn |
|---|---|---|
| CRISPR THERAPEUTICS AG | General Counsel | 01.05.2017 |
American Bar Association
 American Bar Association Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Boston Bar Association
 Boston Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as legal association | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jim Kasinger
| Unternehmen | Position | Ende |
|---|---|---|
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | General Counsel | 24.04.2018 |
| MODERNA, INC. | General Counsel | 01.05.2017 |
PlumChoice, Inc.
 PlumChoice, Inc. Information Technology ServicesTechnology Services Provides business, consumer, and mobility technology services | General Counsel | 01.04.2014 |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 01.08.2011 |
Testa, Hurwitz & Thibeault LLP
 Testa, Hurwitz & Thibeault LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Jim Kasinger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
PlumChoice, Inc.
PlumChoice, Inc. Information Technology ServicesTechnology Services Provides business, consumer, and mobility technology services | Technology Services |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Testa, Hurwitz & Thibeault LLP
Testa, Hurwitz & Thibeault LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Wheaton College (Illinois)
 Wheaton College (Illinois) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Bar Association
American Bar Association Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Boston Bar Association
Boston Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as legal association | Commercial Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
Boston College Law School
 Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
